Coexisting Hepatic Hemangioma Treated Incidentally with Percutaneous Ethanol Injection and Transarterial Chemoembolization in a Case of Hepatocellular Carcinoma

與原位肝細胞癌並存之肝臟血管瘤經酒精注射及經肝動脈栓塞治療後的影像變化

陳韻正(Tom Chen)；陳潤秋(Ran-Chou Chen)；陳慰宗(Wei-Tsung Chen)；李兆祥(Chou-Shian Li)；杜錫杰(Shyi-Jye Duh)；李俊銘(Jiunn-Ming Lii)

中華放射線醫學雜誌

35卷4期（2010 / 12 / 01）

215 - 220

英文

有症狀之肝臟血管瘤普遍以經血管栓塞，經皮穿肝酒精注射，或射頻消融術來治療均為文獻所認可。在此報告一個六十三歲女性患有肝硬化，原發性肝癌，及肝血管瘤。經過經皮穿肝酒精注射及經血管栓塞之後其肝血管瘤仍然存在。

Hepatic hemangiomas are not routinely treated except for large symptomatic lesions. Trans-arterial chemo-embolization (TACE) and percutaneous ethanol injection (PEI) are often used to treat hepatocellular carcinoma (HCC). We report a patient with underlying HCC and a coexisting small hemangioma that was inadvertently treated with both PEI and TACE because of misdiagnosis as an additional HCC. The hemangioma persisted with no visible imaging changes, nor complications. It is important to identify hemangiomas in HCC patients to avoid unnecessary treatment.